MAIOLINO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.137
AS - Asia 1.349
EU - Europa 1.050
SA - Sud America 262
AF - Africa 235
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 14
Totale 8.078
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.010
SG - Singapore 482
CN - Cina 319
IT - Italia 216
HK - Hong Kong 215
BR - Brasile 181
DE - Germania 119
SE - Svezia 116
FI - Finlandia 89
GB - Regno Unito 72
PL - Polonia 65
VN - Vietnam 63
NL - Olanda 48
RU - Federazione Russa 46
FR - Francia 42
IN - India 37
UA - Ucraina 36
CA - Canada 16
IQ - Iraq 15
TR - Turchia 15
ZA - Sudafrica 15
AT - Austria 14
AZ - Azerbaigian 14
TN - Tunisia 14
HN - Honduras 13
PA - Panama 13
AR - Argentina 12
EC - Ecuador 12
IE - Irlanda 12
AE - Emirati Arabi Uniti 11
PY - Paraguay 11
UZ - Uzbekistan 11
BG - Bulgaria 10
ES - Italia 10
IR - Iran 10
KR - Corea 10
MA - Marocco 10
PT - Portogallo 10
XK - ???statistics.table.value.countryCode.XK??? 10
BO - Bolivia 9
CI - Costa d'Avorio 9
CL - Cile 9
CV - Capo Verde 9
MD - Moldavia 9
MK - Macedonia 9
PK - Pakistan 9
SO - Somalia 9
AU - Australia 8
BZ - Belize 8
GN - Guinea 8
GR - Grecia 8
LB - Libano 8
LY - Libia 8
MN - Mongolia 8
MZ - Mozambico 8
PG - Papua Nuova Guinea 8
SI - Slovenia 8
BA - Bosnia-Erzegovina 7
BE - Belgio 7
BF - Burkina Faso 7
BS - Bahamas 7
BY - Bielorussia 7
CM - Camerun 7
CO - Colombia 7
CR - Costa Rica 7
ET - Etiopia 7
GA - Gabon 7
HU - Ungheria 7
JM - Giamaica 7
KG - Kirghizistan 7
KH - Cambogia 7
NZ - Nuova Zelanda 7
PE - Perù 7
RE - Reunion 7
RO - Romania 7
SK - Slovacchia (Repubblica Slovacca) 7
YT - Mayotte 7
AL - Albania 6
AM - Armenia 6
CU - Cuba 6
CY - Cipro 6
DO - Repubblica Dominicana 6
EE - Estonia 6
GE - Georgia 6
GF - Guiana Francese 6
GH - Ghana 6
IS - Islanda 6
JP - Giappone 6
LU - Lussemburgo 6
ML - Mali 6
MX - Messico 6
MY - Malesia 6
NI - Nicaragua 6
PH - Filippine 6
PR - Porto Rico 6
PS - Palestinian Territory 6
SA - Arabia Saudita 6
TL - Timor Orientale 6
TW - Taiwan 6
VE - Venezuela 6
Totale 7.854
Salva come PNG Salva come JPEG
Città #
Fairfield 885
Ashburn 491
Woodbridge 454
Chandler 361
Houston 341
Seattle 321
Singapore 301
Ann Arbor 296
Cambridge 268
Wilmington 266
Hong Kong 207
Santa Clara 153
Boardman 104
Jacksonville 97
Beijing 89
Princeton 81
San Diego 76
Padova 72
Medford 57
Roxbury 53
Bytom 52
Des Moines 44
Helsinki 44
Munich 41
Nanjing 37
Dong Ket 35
New York 35
Los Angeles 20
Jinan 19
Guangzhou 18
London 17
Baku 13
Milan 13
Buffalo 11
Dublin 11
Panama City 11
Falkenstein 10
Hebei 10
São Paulo 10
Tashkent 10
Boston 9
Hefei 9
Shenyang 9
Turku 9
Abidjan 8
Changsha 8
Conakry 8
Ho Chi Minh City 8
Istanbul 8
Nuremberg 8
Rome 8
Ulan Bator 8
Bishkek 7
Jiaxing 7
Nanchang 7
Padua 7
Port Moresby 7
Redwood City 7
San José 7
Seoul 7
Tunis 7
Vienna 7
Addis Ababa 6
Atlanta 6
Cagliari 6
Cochabamba 6
Codognè 6
Council Bluffs 6
Curitiba 6
Dili 6
Hangzhou 6
Hanoi 6
Havana 6
Johannesburg 6
Libreville 6
Managua 6
Maputo 6
Phnom Penh 6
Praia 6
Pristina 6
Quito 6
Sofia 6
Tbilisi 6
Tripoli 6
Accra 5
Amman 5
Baghdad 5
Belize City 5
Brooklyn 5
Bucharest 5
Cape Town 5
Cayenne 5
Chicago 5
Dubai 5
Haiphong 5
Hargeisa 5
Kunming 5
Lanzhou 5
Lilongwe 5
Mamoudzou 5
Totale 5.816
Salva come PNG Salva come JPEG
Nome #
PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy 325
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study 211
Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy 191
A sleep apnoea questionnaire predicts organ damage in hypertensive patients 190
The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale and Design of a Randomized Study (I-Padua) 179
Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease. 171
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 167
Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension 166
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term 163
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. 160
Macrolides for KCNJ5–mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism 157
Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients. 151
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 148
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? 147
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide 142
Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design 141
Under treatment with lipid-lowering drugs of high-risk coronary heart disease patients of the GENICA study 135
Cure with cryoablation of arterial hypertension due to a renin-producing tumor. 135
A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma 135
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women 134
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 133
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization 133
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients. 130
Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients 130
Daily green tea extract supplementation reduces prothrombotic and inflammatory states in dialysis patients 128
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension 128
Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble 127
Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension 126
Relationship of early carotid artery disease with lipoprotein (a), apolipoprotein B, and fibrinogen in asymptomatic essential hypertensive patients and normotensive subjects 123
Atrial fibrillation as presenting sign of primary aldosteronism: Results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study 122
Resolution of Drug-Resistant Hypertension by Adrenal Vein Sampling-guided Adrenalectomy: A Proof-of-Concept Study 121
The T-786 C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in caucasian patients of the GENICA study 119
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. 118
The subtyping of primary aldosteronism by adrenal vein sampling: Sequential blood sampling causes factitious lateralization 117
Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol 114
LB02.07: EFFECT OF ACUTE DA2 DOPAMINERGIC RECEPTOR BLOCKADE ON PERFORMANCE OF ADRENAL VEIN SAMPLING FOR SUBTYPING OF PRIMARY ALDOSTERONISM 112
Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives 111
The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives 108
Oxidative stress in hypertension and cardiovascular-renal remodeling:focus on the renin-angiotensin-aldosterone system 108
Uric acid and cardiovascular-renal disease risk. Insights from a human model opposite to hypertension 105
Recent advances in the diagnosis and management of obstructive sleep apnea 104
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 103
Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in KCNJ5 Mutated Adenoma Cells Ex Vivo 100
Adrenal Venous Sampling: Where Do We Stand? 100
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. 98
Is there an increased heme oxygenase-1 behind the antioxidant effects of green tea on blood pressure and sympathoexcitation reduction? 96
To reconsider (limit) the use of phosphate based food and beverages additives. A real need for health preservation. 95
Primary aldosteronism in elderly, old, and very old patients 95
The cardiovascular consequences of hyperaldosteronism 93
The Molecular Basis of the Interplay between Endothelin-1 and Nitric Oxide and its Relevance for Atherosclerosis and Arterial and Pulmonary Hypertension. 92
Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients 92
Comparative study at computed tomography angiography and intravascular ultrasound of coronary atherosclerotic plaques 92
Magnesium, cardiovascular-renal disease and the Gitelman's syndrome paradox. 89
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study 89
New insights on the renal protective effects of mineralocorticoid receptor antagonists. 87
Arterial Hypertension, Aldosterone, and Atrial Fibrillation 86
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism 86
-786C and G894T variants of the Endothelial Nitric Oxide Synthase Gene and training-induced correction of endothelial dysfunction in coronary artery disease patients. 83
Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis 81
Survival and rehospitalization in patients with severe ischemic mitral regurgitation and multivessel coronary artery disease undergoing different treatment 77
Excessive daytime sleepiness does not correlate with sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea: A proof-of-principle study 77
Moderate-to-severe ischeamic mitral regurgitation and multivessel coronary artery disease: impact of different treatment on survival and rehospitalization 75
Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines! 75
Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure 65
The role of oxidized low-density lipoproteins in atherosclerosis: The myths and the facts 65
Excess arterial damage in hyperaldosteronism: Further evidence from pressure wave analysis 64
Excessive daytime sleepiness, sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea. Reply 55
The Molecular Basis of the Interplay Interventional approach to reduce thromboembolic risk in patients with atrial fibrillation ineligible for oral anticoagulation 55
International multicenter survey on screening and confirmatory testing in primary aldosteronism 48
Totale 8.178
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.375
article - articoli 27.367
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 372
Totale 56.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.071 0 0 43 87 33 40 87 86 120 300 99 176
2021/2022959 13 90 88 83 92 79 51 102 53 25 73 210
2022/2023708 142 82 26 81 104 84 6 52 86 13 25 7
2023/2024327 18 43 51 29 16 41 22 16 8 15 26 42
2024/20251.545 9 106 87 61 223 28 97 133 93 61 242 405
2025/20261.353 320 468 565 0 0 0 0 0 0 0 0 0
Totale 8.178